Apolipoprotein A-IV stimulates duodenal vagal afferent activity to inhibit gastric motility via a CCK1 pathway

Overview of attention for article published in American Journal of Physiology: Regulatory, Integrative & Comparative Physiology, April 2004

Altmetric Badge

Mentioned by

patent: 5 patents

Readers on

mendeley: 28 Mendeley

So far, Altmetric has seen 5 patents that reference this research output.

Method of treating hyperglycemic disorders using apolipoprotein AIV

Grant US-10232019-B2

United States of America

Method of treating diabetes using non-glycosylated apolipoprotein A-IV

Grant US-9951120-B2

United States of America

Method of treating type I diabetes using apolipoprotein A-IV

Grant US-9730980-B2

United States of America

Apolipoprotein AIV as an antidiabetic peptide

Grant US-9266941-B2

United States of America

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.